Videos and news
Genostics® partners with world-class cancer research laboratories in Europe to bring the very best in personalised cancer testing to the Australian and New Zealand medical communities.
We engage with pioneering practitioners who seek to discover the exact nature of each patient's cancer. These practitioners use Genostics® tests to help design personalised treatment plans and to closely monitor the effectiveness of therapies.
Specialising in the field of Oncology, we are proud to be bringing the future of personalised cancer testing to patients, today.
24 Sept 2015
Dr. Fluhrer will be presenting at the World CTC Symposium in Melbourne on 10 October 2015. Genostics will be available for general enquiries in the exhibition hall
August 5 2015
Your lifestyle is an on/off switch for your genes ...Find out more
June 30, 2015
Detecting the rare, renegade cancer cells ...Learn more
June 18, 2015
Survival of the fittest in cancer ...Quick read of this blog
June 8, 2015
"Even if surgery, chemotherapy, or radiation removes all traces of known cancer, there is still a risk of the cancer returning, often in a distant location in the body. This may occur as a result of CTCs."
...Read the article
June 2, 2015
Which chemotherapy kills the cells responsible for cancer spread, doctor?
May 18, 2015
Gene expression and the regulation of genes
...Read this article
May 11, 2015
Genetics, explained simply
...Read this blog post
May 5, 2015
What is a biomarker, and how are CTCs defined as both a biomarkers and carriers of biomarkers? ...Learn more
April 27, 2015
Circulating Tumour Cells: tell me more ...Read this article
April 20, 2014
How cancer spreads: the biology of metastasis ...Quick view
April 13 2015
DNA, Cancer, and what it takes for a cell to become cancerous ...Read this blog post
We are very excited to announce the launch of the world's first Circulating Tumour Cell blog, written specifically for practitioners and their patients.
Dr. Fluhrer gives NewYou an in-depth look at the
intertwined world of cancer testing and molecular medicine.
"In what specific ways can personalised cancer testing and molecular medicine revolutionise the way people treat and think of cancer?
Every person is a separate individual, similarly every cancer is also ‘individual’ to the person affected, in a manner of speaking; cancer is heterogeneous. Cells in a malignant tumour can include cancer stem cells, promoter cells, communication cells, supportive cells, immune cells etc. Some of the cancer cells produce proteins that inhibit the immune system to recognise them and kill it." ...Read the rest of this article
'Best of the best' publication
Prof. Pachmann's poster, outlining the use of Maintrac® technology in uncovering the heterogenous nature of Circulating Tumour Cells, was awarded 'The best of the best' poster at the Clinical Oncology Society of Australia conference. Somatic mutations of the EGFR, KRAS and BRAF genes: homogeneitiy in single cells from cell lines and heterogeneity in Circulating Epithelial Tumor Cells (CETCs) as determined using cobas® z480 analyzer (2014) ...Quick view